1. Department of Preventive Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
2. WHO Collaborating Centre for Vaccine Safety, Santiago de Compostela, Spain
3. Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain
4. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBER-ES), Carlos III Health Institute, Madrid, Spain
5. Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública-CIBERESP), Carlos III Health Institute, Madrid, Spain
6. Pharmacotherapy Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain
7. Basque Country Pharmacovigilance Unit, University Hospital of Galdakao-Usansolo, Osakidetza, Spain
8. Pharmacology Department, Medicine and Nursing Faculty, University of the Basque Country, Barakaldo, Spain
9. Osakidetza Basque Health Service, Pharmacy Department, Urduliz Hospital, Urduliz, Spain
10. Department of Gastroenterology and Hepatology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
11. Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain
12. Department of Pharmacology, Therapeutics and Toxicology, Catalonian Institute of Pharmacology, Clinical Pharmacology Service, Vall d’Hebron University Teaching Hospital, Autonomous University, Barcelona, Spain
13. Centre for Research on Drug Safety (CESME), Valladolid University, Valladolid, Spain
14. Centro de Saúde de Vite, Santiago de Compostela, Spain